205 related articles for article (PubMed ID: 37020393)
1. Epigenetics and cutaneous neoplasms: from mechanism to therapy.
Gibson F; Hanly A; Fisher R; Wyant WA; Wu M; Collard M; Alani RM
Epigenomics; 2023 Feb; 15(3):167-187. PubMed ID: 37020393
[TBL] [Abstract][Full Text] [Related]
2. Current insights into the epigenetic mechanisms of skin cancer.
Sang Y; Deng Y
Dermatol Ther; 2019 Jul; 32(4):e12964. PubMed ID: 31081988
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA methylation in cutaneous malignancies.
van Doorn R; Gruis NA; Willemze R; van der Velden PA; Tensen CP
Semin Oncol; 2005 Oct; 32(5):479-87. PubMed ID: 16210089
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic biomarkers in skin cancer.
Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of skin cancer: Interventions by selected bioactive phytochemicals.
Penta D; Somashekar BS; Meeran SM
Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):42-49. PubMed ID: 28976029
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.
Lai P; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):34-51. PubMed ID: 33628583
[TBL] [Abstract][Full Text] [Related]
7. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics of Cutaneous T-Cell Lymphomas.
Hara N; Sawada Y
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
[TBL] [Abstract][Full Text] [Related]
10. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.
Rao RC; Chan MP; Andrews CA; Kahana A
Cell Oncol (Dordr); 2018 Dec; 41(6):693-698. PubMed ID: 30215205
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
13. Methylation status, mRNA and protein expression of the SMAD4 gene in patients with non-melanocytic skin cancers.
Gürsel Ürün Y; Budak M; Usturalı Keskin E
Mol Biol Rep; 2023 Sep; 50(9):7295-7304. PubMed ID: 37428273
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Regulation in Melanoma: Facts and Hopes.
Giunta EF; Arrichiello G; Curvietto M; Pappalardo A; Bosso D; Rosanova M; Diana A; Giordano P; Petrillo A; Federico P; Fabozzi T; Parola S; Riccio V; Mucci B; Vanella V; Festino L; Daniele B; Ascierto PA; Ottaviano M; On Behalf Of Scito Youth
Cells; 2021 Aug; 10(8):. PubMed ID: 34440824
[TBL] [Abstract][Full Text] [Related]
15. From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention.
Mitsiogianni M; Amery T; Franco R; Zoumpourlis V; Pappa A; Panayiotidis MI
Pharmacol Ther; 2018 Oct; 190():187-201. PubMed ID: 29890115
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of melanoma: implications for immune-based therapies.
Fratta E; Sigalotti L; Covre A; Parisi G; Coral S; Maio M
Immunotherapy; 2013 Oct; 5(10):1103-16. PubMed ID: 24088079
[TBL] [Abstract][Full Text] [Related]
17. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
[TBL] [Abstract][Full Text] [Related]
18. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation and inflammatory skin diseases.
Mervis JS; McGee JS
Arch Dermatol Res; 2020 Sep; 312(7):461-466. PubMed ID: 31696298
[TBL] [Abstract][Full Text] [Related]
20. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.
Anestopoulos I; Kyriakou S; Tragkola V; Paraskevaidis I; Tzika E; Mitsiogianni M; Deligiorgi MV; Petrakis G; Trafalis DT; Botaitis S; Giatromanolaki A; Koukourakis MI; Franco R; Pappa A; Panayiotidis MI
Pharmacol Ther; 2022 Dec; 240():108301. PubMed ID: 36283453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
